Norman Häfner

16PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Molecular targetsMain group metal chemistryTransition metal chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Feb 01, 2025
Genome-Wide Association Analyses of HPV16 and HPV18 Seropositivity Identify Susceptibility Loci for Cervical Cancer.

Theresa Beckhaus, Linda Kachuri, Taishi Nakase

|Oct 23, 2024
Germline variants of homology-directed repair or mismatch repair genes in cervical cancer.

Lara Kokemüller, Dhanya Ramachandran, Peter Schürmann

|Sep 06, 2023
CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.

Karin Bauer, Sigrid Machherndl-Spandl, Lukas Kazianka

|Mar 29, 2023
Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug-Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines.

Marie-Christin Barth, Norman Häfner, Ingo B Runnebaum

|Jun 24, 2022
Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with O,S Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues.

Jana Hildebrandt, Norman Häfner, Helmar Görls

|May 14, 2022
Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.

Jana Hildebrandt, Norman Häfner, Daniel Kritsch

Pageof 3

Frequent Collaborators

7 joint publications

Matthias Dürst

4 joint publications

Wolfgang Weigand

2 joint publications

Peter A Fasching

2 joint publications

Thilo Dörk